Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety study of MP03-33 versus Astelin in chronic allergic or nonallergic rhinitis
2006-001510-32Phase 3Completed
- Sponsor
- Meda
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of azelastine in allergic rhinitis (AR) and non-allergic rhinitis (NAR) (2 arms), sponsored by Meda. Primary endpoint: Long-term safety and tolerability. Started Jun 2006; status: completed.
02
Drugs
azelastine
03
Conditions
allergic rhinitis (AR)non-allergic rhinitis (NAR)
Beyond the preview
Go deeper on 2006-001510-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001510-32.